Visceral leishmaniasis: Resistance to reinfection in the liver following chemotherapy in the BALB/c mouse
- 30 April 1989
- journal article
- research article
- Published by Elsevier in Experimental Parasitology
- Vol. 68 (4) , 375-381
- https://doi.org/10.1016/0014-4894(89)90122-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependentJournal of Pharmacy and Pharmacology, 1988
- Immunochemotherapy for Intracellular Leishmania donovani Infection: Interferon Plus Pentavalent AntimonyThe Journal of Infectious Diseases, 1988
- Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovaniParasite Immunology, 1987
- Subpopulations of T Lymphocytes in Kenyan Patients with Visceral LeishmaniasisThe American Journal of Tropical Medicine and Hygiene, 1987
- Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconateJournal of Pharmacy and Pharmacology, 1986
- Liposomes as drug carriers in leishmaniasis and malariaParasitology Today, 1986
- The preparation and properties of niosomes—non-ionic surfactant vesiclesJournal of Pharmacy and Pharmacology, 1985
- Immunosuppression associated with visceral leishmaniasis of hamstersParasite Immunology, 1985
- East African kala-azar with special reference to the pathology, prophylaxis and treatmentTransactions of the Royal Society of Tropical Medicine and Hygiene, 1959